The president of the Canary Islands, Ángel Víctor Torres, has guaranteed this Thursday that the decision of the Ministry of Health and the autonomous communities to suspend the administration of doses of the Oxford AstraZeneca vaccine to people under 60 years of age "will not alter the objective of 70% of the Canarian population to be immunized this summer ".
During an appearance at the headquarters of the Presidency for the presentation of the new national and international routes of the Binter company, the President of the Canary Islands stressed that, on Wednesday, April 7th, the Canary Islands managed to vaccinate 14,407 people and that it maintains its potential to administer 30,000 daily doses "if there were supplies for it."
Torres has acknowledged that the decision on AstraZeneca is "a setback" that will make the vaccination rate drop "a little" in the coming days , but has defended that "the reordering of the age groups and the new planning will hardly last 48 hours".
The new decision adopted in Spain implies that this vaccine, which was initially only applied to people under 55 years of age, will now be supplied only to the group between 60 and 65 years of age.
This Wednesday, from the European Medicines Agency they recognized that the cases of thrombosis detected in several countries may be related to this vaccine, but they insisted that it would be a "very rare" and not a frequent side effect. In addition, it once again defended that the benefits are much higher than the possible risks, although several countries have suspended its administration, and Spain has again joined them, which in its case has limited it to a very specific age group.
Regarding people under 60 years of age who had already received the first dose of AstraZeneca and who were awaiting the second, no decision was made this Wednesday. "The immunization will be completed in the way that the experts decide in the next few hours," they have indicated in this regard from the Government of the Canary Islands.
Comments